Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
2197–2232
Headlines
2925
Sources here
16
Companies here
22
Current section United States Medical Instruments & Supplies news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Innovative Eyewear, Inc. Revenue Breakdown – NASDAQ:LUCY

Innovative Eyewear, Inc. (NASDAQ: LUCY) generated $2.66 million USD in revenue last year, with its e-commerce segment contributing the most at $2.43 million USD. All of the company's revenue originated from the United States, which saw a slight increase from $1.64 million USD the …

LUCY main company
Sharemaestro market context Price below Trend Line 52 weeks -63.1% · Next-week setup negative 33.2% LUCY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intuitive Surgical, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Intuitive Surgical, Inc. recently reported earnings that surpassed analyst expectations, driven by higher revenue and earnings per share. Following these strong results, analysts have revised their price targets and earnings estimates upwards, indicating a positive outlook for the company's future performance. The general sentiment …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Did You Lose Money on Embecta Corp. (EMBC)? Levi & Korsinsky Urges Investors to Act Before August 17, 2026

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ:EMBC) on behalf of investors who suffered losses due to alleged securities fraud between November 25, 2025, and May 4, 2026. The lawsuit claims Embecta made misleading statements regarding its …

EMBC main company
Sharemaestro market context New activity signal 52 weeks -63.1% EMBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ICU Medical, Inc. Revenue Breakdown – TRADEGATE:IC7

ICU Medical, Inc. (TRADEGATE:IC7) generated 1.88 billion EUR in revenue last year, with its Consumables segment being the top performer, contributing 944.33 million EUR. The United States was the largest geographical contributor, accounting for 1.15 billion EUR of the company's revenue. The article provides …

ICUI main company
Sharemaestro market context Trend signal active 52 weeks +42.8% ICUI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

West Pharmaceutical Services (WST) Stock Sees Margin Improvement Narrative Backed By Q2 2026 Results

West Pharmaceutical Services (WST) reported a strong Q2 2026 with increased revenue and basic EPS, demonstrating improved profitability with a trailing twelve-month net profit margin of 17%. The company's margin strength is attributed to higher-margin High Value Product components and GLP-1 related products, which …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Repligen Corp|Price:131.970|Chg%:-5.630

This article provides a company profile for Repligen Corporation (RGEN), a global life sciences company specializing in bioprocessing technologies. It details the company's focus areas, product portfolio, and key financial information. The article also lists company executives, their shareholdings, and institutional ownership data for …

RGEN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% RGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis

Sanara Medtech Inc (SMTI) currently holds a financial score of 7.31, ranking 117 out of 155 in the pharmaceuticals industry, indicating stable financial health and high operating efficiency. The company reported a significant year-over-year revenue increase of 18.62% to $27.80 million, and its net …

SMTI main company
Sharemaestro market context Trend signal active 52 weeks +0.6% · Next-week setup negative 41.2% SMTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Repligen Corp (RGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Repligen Corp (RGEN) by business segment and by region. For FY2025, filtration products were the largest segment, contributing 54.58% of revenue, while North America was the largest regional market at 49.00%. The data highlights the company's …

RGEN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% RGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AtriCure (ATRC) Stock Faces Mixed Views As EPS Turnaround Tests Margin Narratives

AtriCure (ATRC) reported strong Q2 2026 results with a significant EPS turnaround and increased revenue, driven by improved margins and operating leverage rather than just revenue growth. While the profitability improvement supports bullish sentiment, the widely divergent valuation metrics (low DCF fair value vs. …

ATRC main company
Sharemaestro market context Trend signal started 52 weeks +17.6% ATRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Icu Medical (ICUI) Q1 2024 Earnings Report - Results, Call & Slides

ICU Medical (ICUI) reported its Q1 2024 earnings, beating analyst expectations with an actual EPS of $0.96 against a consensus of $0.82 and revenue of $565.96 million compared to an expected $552.25 million. Despite beating estimates, the company's EPS saw a year-over-year decrease from …

ICUI main company
Sharemaestro market context Trend signal active 52 weeks +42.8% ICUI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NVST|Envista Holdings Corp|Price:26.330|Chg%:+0.140

Envista Holdings Corp (NVST) shows strong fundamentals and high growth potential, despite trading sideways. The company is considered fairly valued within the Healthcare Equipment & Supplies industry and has high institutional ownership. Analysts have a positive outlook, with a 'Buy' rating and a target …

NVST main company
Sharemaestro market context Trend signal started 52 weeks +29.2% NVST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OraSure Technologies, Inc. Revenue Breakdown – LSX:881351

OraSure Technologies, Inc. (LSX:881351) generated 97.93 million EUR in revenue last year, with its Human Immunodeficiency Virus segment contributing the most at 42.40 million EUR. The United States was the largest regional contributor, accounting for 66.63 million EUR of the company's revenue.

OSUR main company
Sharemaestro market context Trend signal active 52 weeks +28.0% · Next-week setup negative 40.2% OSUR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

EMBC|Embecta Corp|Price:3.295|Chg%:+0.045

Embecta Corp (EMBC) is a global medical device company focusing on diabetes care, offering a portfolio of pen needles, syringes, and safety injection devices. The company's executives and their shareholdings are detailed, with Mr. Devdatt Kurdikar serving as Chairman, President, and CEO. Institutional ownership …

EMBC main company
Sharemaestro market context New activity signal 52 weeks -63.1% EMBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Solventum Corp (SOLV) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Solventum Corp (SOLV), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. According to the analysis, SOLV's price is currently suitable for range-bound swing trading, with a …

SOLV main company
Sharemaestro market context Trend signal active 52 weeks +20.4% · Next-week setup negative 34.7% SOLV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AngioDynamics (ANGO) SVP receives shares from PSU vesting, with tax withholding

Chad Thomas Campbell, SVP/GM Vascular Access at AngioDynamics (ANGO), received 6,466 shares of common stock from the vesting of performance share units, which were originally granted on July 19, 2023. To cover tax withholding obligations, 2,330 shares were disposed of at $13.82 per share. …

ANGO main company
Sharemaestro market context Trend signal active 52 weeks +67.7% ANGO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Microbot Medical (MBOT) Short Interest & Short Float | Updated Jul 2026

Microbot Medical (MBOT) currently has 7.49 million shares sold short as of July 15, 2026, representing 11.71% of its public float, which is a 1.92% increase from the prior report. The short interest ratio stands at 10.9 days to cover, indicating a significant level …

MBOT main company
Sharemaestro market context Price below Trend Line 52 weeks -59.7% MBOT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Microbot Medical Inc (MBOT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Microbot Medical Inc (MBOT) as of July 24, 2026. The company's valuation score is 8.19, placing it 164th out of 386 in the Biotechnology & Medical Research industry. Key financial metrics like P/E, P/B, and P/CF ratios …

MBOT main company
Sharemaestro market context Price below Trend Line 52 weeks -59.7% MBOT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Harvard Bioscience Inc (HBIO) Institutional Confidence

Harvard Bioscience Inc (HBIO) has an institutional shareholding score of 5.00, placing it 108th in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 54.17%, showing a 13.62% increase quarter-over-quarter. James Simons is the largest institutional shareholder, holding 2.25% of outstanding shares.

HBIO main company
Sharemaestro market context Trend signal active 52 weeks +36.1% · Next-week setup negative 37.0% HBIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AngioDynamics (NASDAQ: ANGO) executive settles 20,052 performance units

Warren Nighan Jr., SVP Quality and Regulatory at AngioDynamics (NASDAQ: ANGO), had a 2023 performance share unit grant settle, resulting in 5,694 shares of common stock being issued from a target of 20,052 units. The remaining units were forfeited, and 1,671 shares were withheld …

ANGO main company
Sharemaestro market context Trend signal active 52 weeks +67.7% ANGO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AngioDynamics Inc. (ANGO) SVP receives 8,047 shares, 4,506 withheld for tax

AngioDynamics Inc.'s SVP International, Laura Piccinini, received 8,047 common shares from the vesting of performance share units granted in July 2023. Of these, 4,506 shares were withheld for tax obligations at $13.82 per share, and the remaining 20,289 units from the original grant were …

ANGO main company
Sharemaestro market context Trend signal active 52 weeks +67.7% ANGO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors

West Pharmaceutical Services Inc. (WST) stock fell 7.67% on Friday, closing at $328.20. This underperformance occurred despite a positive trading session for the broader market, with the S&P 500 rising 0.05% and the Dow Jones Industrial Average rising 0.46%. This marks the stock's third …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?

Baxter International Inc. (BAX) is scheduled to release its second-quarter 2026 results on July 30, with expectations of continued operational headwinds impacting performance. The company anticipates revenue decline and a significant drop in earnings per share due to manufacturing inefficiencies, inflationary pressures, and issues …

BAX main company
Sharemaestro market context Trend signal active 52 weeks +9.8% BAX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Azenta, Inc. Revenue Breakdown – LSE:0HQ1

Azenta, Inc. (LSE:0HQ1) generated a total revenue of $593.82 million USD last year. The Sample Management Solutions segment was the top-performing segment, contributing $324.59 million USD, while the United States was the largest regional contributor with $365.00 million USD in revenue.

AZTA main company
Sharemaestro market context Price above Trend Line 52 weeks +5.8% AZTA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BioLife Solutions (BLFS) Faces Fairness Probes After Repligen Agrees To Buy It

BioLife Solutions (BLFS) is facing fairness probes from several law firms after Repligen agreed to acquire the company. The investigations focus on ensuring the transaction terms are fair to BioLife Solutions shareholders, considering the agreed US$31.00 per share price which includes a mix of …

BLFS main company RGEN mentioned
Sharemaestro market context Trend signal active 52 weeks +35.4% BLFS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pulse Biosciences, Inc Revenue Breakdown – NASDAQ:PLSE

This article provides a detailed revenue breakdown for Pulse Biosciences Inc (PLSE), categorizing its revenue by business segments (Systems, Cycle units) and geographical regions (North America, Rest of World). The data presented shows that as of the updated information on Tuesday, January 6, the …

PLSE main company
Sharemaestro market context Trend signal active 52 weeks +161.2% PLSE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Anteris Technologies Global Corp (AVR) Financials

This article provides a detailed financial overview of Anteris Technologies Global Corp (AVR), including its income statement, balance sheet, and cash flow statement. It highlights key financial indicators such as EPS, revenue, net profit, and various ratios, alongside upcoming earnings dates and analyst ratings. …

AVR main company
Sharemaestro market context Trend signal active 52 weeks +126.5% AVR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Flash (ATRC) AtriCure, Inc. Posts Q2 Adjusted EPS $0.18 per Share, vs. FactSet Est of $0.00

AtriCure, Inc. (ATRC) reported strong Q2 adjusted earnings per share of $0.18, significantly surpassing the FactSet estimate of $0.00. The company also announced Q2 revenue of $153.6 million, exceeding the FactSet estimate of $151.8 million, and provided an optimistic full-year 2026 adjusted EPS guidance …

ATRC main company
Sharemaestro market context Trend signal started 52 weeks +17.6% ATRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS

Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of BioLife Solutions, Inc. (NasdaqCM: BLFS) to Repligen Corporation (NasdaqGS: RGEN). KSF is concerned that the offered consideration of $11.25 in cash and 0.1442 shares of Repligen common stock per BioLife share may …

BLFS main company
Sharemaestro market context Trend signal active 52 weeks +35.4% BLFS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

UTMD|Utah Medical Products Inc|Price:67.140|Chg%:+2.960

Utah Medical Products Inc (UTMD) shows strong fundamentals and high growth potential, despite a weak stock market performance recently. Its valuation is considered fairly valued within the Healthcare Equipment & Supplies industry. The company is in a growing phase with high and stable dividends, …

UTMD main company
Sharemaestro market context Trend signal active 52 weeks +18.8% UTMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SOLN5957403 Bond Profile — Key Metrics

This article provides key metrics for the Solventum Corporation 5.45% 13-MAR-2031 bond, identified as SOLN5957403 FINRA. It details the issuer, issue date, maturity date, outstanding amount, face value, minimum denomination, and coupon rate. Solventum Corp. is described as a healthcare company founded on January …

SOLV main company
Sharemaestro market context Trend signal active 52 weeks +20.4% · Next-week setup negative 34.7% SOLV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics experienced stock declines following concerns about a rising number of uninsured patients, as highlighted in HCA Healthcare's recent earnings report. HCA reported a "negative payer mix shift" leading to a $400 million reduction …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sanara Medtech Inc (SMTI) Institutional Confidence

Sanara Medtech Inc (SMTI) currently holds an institutional shareholding score of 3.00, placing it 92nd out of 155 companies in the Pharmaceuticals industry. The institutional shareholding proportion has increased by 18.63% quarter-over-quarter to 15.50%. James Simons is the largest institutional shareholder, holding 0.71% of …

SMTI main company
Sharemaestro market context Trend signal active 52 weeks +0.6% · Next-week setup negative 41.2% SMTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Robotics firm Brooks Automation weighs IPO - Bloomberg By Investing.com

Brooks Automation, a robotics and software automation company, is reportedly considering an initial public offering. The company, backed by Thomas H. Lee Partners, was formed after a $3 billion carve-out from the former Brooks Automation, with its life sciences arm renamed Azenta Inc. Deliberations …

AZTA main company
Sharemaestro market context Price above Trend Line 52 weeks +5.8% AZTA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Unveils New Digital Dentistry Innovations

Align Technology has introduced new innovations within its Align Digital Platform, designed to enhance the visualization, planning, and treatment aspects of digital dentistry. These updates include improved patient communication tools, more precise treatment planning capabilities for Invisalign cases, and streamlined workflows for both orthodontic …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intuitive Surgical (ISRG) Unveils Five Layer AI Plan And Live Telesurgery Demo

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Intuitive Surgical revealed a five layer AI framework for its surgical platforms. The company …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context